IQV
IQVIA HOLDINGS INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$266.42
−1.12%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $3.25
- Revenue estimate
- $4.4B
Latest reported
- Last report date
- Jul 28, 2026
- EPS actual
- $3.15
- EPS estimate
- $3.03
- Revenue actual
- $4.4B
- Revenue estimate
- $4.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 4
- Avg surprise (4Q)
- +2.2%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $269
- PT range
- $230 – $288
- Analysts
- 8
7 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 28, 2026 | $3.03 | $3.15 | Beat 3.96% | $4.4B |
| May 5, 2026 | $2.83 | $2.90 | Beat 2.47% | $4.2B |
| Feb 5, 2026 | $3.39 | $3.42 | Beat 0.88% | $4.4B |
| Jul 22, 2025 | $2.77 | $2.81 | Beat 1.44% | $4.0B |
| Feb 6, 2025 | $3.11 | $3.12 | Beat 0.35% | $4.0B |
| Oct 31, 2024 | $2.81 | $2.84 | Beat 0.89% | $3.9B |
| Jul 22, 2024 | $2.56 | $2.64 | Beat 3.21% | $3.8B |
| May 2, 2024 | $2.49 | $2.54 | Beat 2.01% | $3.7B |
| Feb 14, 2024 | $2.82 | $2.84 | Beat 0.71% | $3.9B |
| Nov 1, 2023 | $2.46 | $2.49 | Beat 1.22% | $3.7B |
| Aug 1, 2023 | $2.37 | $2.43 | Beat 2.53% | $3.7B |
| Apr 27, 2023 | $2.41 | $2.45 | Beat 1.66% | $3.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026